News and events

Published Nov. 17, 2017 9:56 AM

Karl-Johan Malmberg has received funding from The Norwegian Cancer Society of 8,95 mill. NOK.

Published Oct. 19, 2017 2:46 PM

The research group of Johanna Olweus, together with Kite Pharma, will further develop breakthrough technology on immunotherapy against cancer.

Published July 31, 2017 1:22 PM

In connection with American Society of  Clinical Oncology (ASCO) naming immunotherapy as the Society’s advance of the year, Professor Johanna Olweus and Professor Karl-Johan Malmberg was interviewed by Dagens Medisin, April 12th 2017.

Published Mar. 15, 2017 3:31 PM

Malmberg Lab enter into partnership with Fate Therapeutics Inc. to develop off-the-shelf NK cell therapy

Published Feb. 16, 2017 9:58 AM

The conference explores possibilities for how to create a leading Nordic Life Science hub for research, education, innovation and business focusing this year on health.

Published Nov. 28, 2016 12:41 PM

Professor and co-Director of K.G. Jebsen Centre of Immunotherapy Karl-Johan Malmberg speaks on "Harnessing Natural Killer Cells in Cancer Immunotherapy" during STREAM mini-symposium.

Published Nov. 22, 2016 12:24 PM

JCIT Director Professor Johanna Olweus was invited to present immunotherapy, current strategies and comment on K.G. Jebsen Centre’s current work.

Published Nov. 18, 2016 9:39 AM

Oslo University Hospital gives prizes to six outstanding research articles with key authors from the hospital every six months.

Published Oct. 31, 2016 11:21 AM

Every year The Norwegian Cancer Society supports cancer Research. In 2016 a total of 40 million NOK was granted to immunotherapy.

Published Mar. 11, 2016 12:58 PM
Published Mar. 3, 2016 11:37 AM
Published Feb. 16, 2016 11:37 AM
Published Dec. 1, 2015 2:27 PM

Researchers from the KG Jebsen Centres for Cancer Immunotherapy (JCIT) and Inflammation Research (JIRC) collaborate to develop tomorrow's tools for protein analysis.

Published Sep. 9, 2015 9:53 AM
Published Sep. 9, 2015 9:34 AM

Karl-Johan Malmberg, PI in the Jebsen Center for cancer Immunotherapy has been appointed as visiting professor at the Karolinska Institute (KI).

Published Sep. 9, 2015 9:19 AM
Published Sep. 9, 2015 9:17 AM
Published Sep. 8, 2015 10:38 AM

Poorly validated antibodies represent one of the largest problems in bio-medical research.